Charles River Laboratories International (CRL) is currently trading near its average analyst target, prompting questions about its fair valuation. The analysis explores whether the stock has additional upside potential or if its current price reflects its intrinsic value.
Charles River Laboratories (CRL) Valuation: Is Further Upside Possible?
CRLstock_valuationanalyst_targetsbiotechnologyhealthcare
